| JXHL2000112 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2020-05-27 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd;AstraZeneca AB | In Review | 2020-05-26 | view |
| JYHB1801229 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2018-10-17 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd;AstraZeneca AB;Abbvie Deutschland Gmbh & Co KG | Certificate Issued | 2018-11-26 | view |
| JYHB2300513 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs | Supplementary Application | 2023-09-07 | | AstraZeneca AB | | | view |
| CYHS2101943 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(4) | Generic Drug | 2021-10-28 | | Qilu Pharmaceutical (Hainan) Co Ltd | | | view |
| JXHB2000049 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs | Supplementary Application | 2020-11-20 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd;AstraZeneca AB | In Review | 2020-11-20 | view |
| JXHS1900038 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2019-03-25 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd;AstraZeneca AB;Abbvie Deutschland Gmbh & Co KG | Certificate Issued | 2021-07-28 | view |
| CYHB2402054 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(4) | Supplementary Application | 2024-12-04 | | Huadong Medicine (Xi'an) Bodyguard Pharmaceutical Co Ltd;Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd | | | view |
| CYHS2300075 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(4) | Generic Drug | 2023-01-11 | | Jiangsu Litair Pharmaceutical Co Ltd;Nanjing F&S Pharmatech Co Ltd | | | view |
| JXHL2100038 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2021-02-03 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd;AstraZeneca AB | In Review | 2021-02-02 | view |
| JXHL2000097 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2020-05-18 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd;AstraZeneca AB | In Review | 2020-05-16 | view |
| JYHB2500280 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2025-05-22 | | Abbvie Ltd;AstraZeneca AB | | | view |
| JXHS1700047 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2017-12-01 | AstraZeneca Pharmaceuticals LP | Astrazeneca Pharmaceuticals Lp;Abbvie Deutschland Gmbh & Co KG | Certificate Issued | 2018-08-23 | view |
| JXHB2300095 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs | Supplementary Application | 2023-06-10 | | AstraZeneca AB | | | view |
| JXHB2200123 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(2.4) | Supplementary Application | 2022-09-02 | | AstraZeneca AB | | | view |
| JYHB2001608 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2020-08-28 | | Abbvie Ltd;AstraZeneca AB | Filed | 2020-09-11 | view |
| JXHL1800160 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2018-11-21 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd;AstraZeneca AB | In Review | 2018-11-20 | view |
| JXHS2400080 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2024-10-11 | | AstraZeneca AB;Astrazeneca Investment (China) Co Ltd | | | view |
| JYHZ2200256 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(5.1) | License Renew | 2022-09-22 | | Abbvie Ltd;AstraZeneca AB;Astrazeneca Investment (China) Co Ltd | | | view |
| JXHB2100001 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs | Supplementary Application | 2021-01-06 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd;AstraZeneca AB | In Review | 2021-01-05 | view |
| JXHL1900241 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2019-10-16 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd;AstraZeneca AB | In Review | 2019-10-14 | view |
